CoChat

BioPhi: A platform for antibody design, humanization and humanness evaluation based on natural antibody repertoires and deep learning

Open access
Prihoda, David, Maamary, Jad, Waight, Andrew, Juan, Veronica, Fayadat-Dilman, Laurence, Svozil, Daniel, Bitton, Danny A. · 2021 · mAbs

Preprint — published as 10.1080/19420862.2021.2020203 · Paper page

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Despite recent advances in transgenic animal models and display technologies, humanization of mouse sequences remains the primary route for therapeutic antibody development. Traditionally, humanization is manual, laborious, and requires expert knowledge. Although automation efforts are advancing, existing methods are either demonstrated on a small scale or are entirely proprietary. To predict the immunogenicity risk, the human-likeness of sequences can be evaluated using existing humanness scores, but these lack diversity, granularity or interpretability. Meanwhile, immune repertoire sequencing has generated rich antibody libraries such as the Observed Antibody Space (OAS) that offer augmented diversity not yet exploited for antibody engineering. Here we present BioPhi, an open-source platform featuring novel methods for humanization (Sapiens) and humanness evaluation (OASis). Sapiens is a deep learning humanization method trained on the OAS database using language modeling. Based on an in silico humanization benchmark of 177 antibodies, Sapiens produced sequences at scale while achieving results comparable to that of human experts. OASis is a granular, interpretable and diverse humanness score based on 9-mer peptide search in the OAS. OASis separated human and non-human sequences with high accuracy, and correlated with clinical immunogenicity. Together, BioPhi offers an antibody design interface with automated methods that capture the richness of natural antibody repertoires to produce therapeutics with desired properties and accelerate antibody discovery campaigns. BioPhi is accessible at https://biophi.dichlab.org and https://github.com/Merck/BioPhi .

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2021.08.08.455394

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. BioPhi integrated pipeline for bulk humanization (Sapiens) and humanness evaluation (OASis).
Figure 1. BioPhi integrated pipeline for bulk humanization (Sapiens) and humanness evaluation (OASis).CC BY-NC · PubMed Central
Figure 2. Diversity of human antibody germlines compared to human antibody repertoires from OAS.
Figure 2. Diversity of human antibody germlines compared to human antibody repertoires from OAS.CC BY-NC · PubMed Central
Figure 3. OASis provides agranular and interpretable humanness score that is able to separate therapeutic antibodies of different origin.
Figure 3. OASis provides agranular and interpretable humanness score that is able to separate therapeutic antibodies of different origin.CC BY-NC · PubMed Central
Figure 4. Attention within the Sapiens neural network captures long-range dependencies between antibody loops.
Figure 4. Attention within the Sapiens neural network captures long-range dependencies between antibody loops.CC BY-NC · PubMed Central
Figure 5. Sapiens achieved abalanced humanness-preservation tradeoff on 25 antibodies with known parental sequences.
Figure 5. Sapiens achieved abalanced humanness-preservation tradeoff on 25 antibodies with known parental sequences.CC BY-NC · PubMed Central
Figure 6. Evaluation of humanization methods on alarge scale using 152 humanized therapeutic antibodies with putative parental sequences.
Figure 6. Evaluation of humanization methods on alarge scale using 152 humanized therapeutic antibodies with putative parental sequences.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 44

  1. 2020, Monoclonal Antibodies in Cancer Therapy, Antibodies, 9, 34, 10.3390/antib9030034 · DOI · Paper page
  2. 2020, Antibody therapeutics and immunoregulation in cancer and autoimmune disease, Seminars in Cancer Biology, 64, 1, 10.1016/j.semcancer.2019.06.001 · DOI · Paper page
  3. Kaplon, H. , & Reichert, J. M. (2021). Antibodies to watch in 2021. MAbs, 13(1). https://doi.org/10.1080/19420862.2020.1860476 · DOI · Paper page
  4. 10.1016/j.ymeth.2005.01.001 · DOI · Paper page
  5. 2013, Antibody humanization methods – a review and update, Biotechnology and Genetic Engineering Reviews, 29, 175, 10.1080/02648725.2013.801235 · DOI · Paper page
  6. Valldorf, B. , Hinz, S. C. , Russo, G. , Pekar, L. , Mohr, L. , Klemm, J. , … Zielonka, S. (2021, March 23). Antibody display technologies: Selecting the cream of the crop. Biological Chemistry. https://doi.org/10.1515/hsz-2020-0377 · DOI
  7. 10.1038/321522a0 · DOI · Paper page
  8. 10.1016/0022-2836(92)91010-M · DOI · Paper page
  9. 10.1016/j.jmb.2007.02.100 · DOI · Paper page
  10. 2013, Monoclonal antibody humanness score and its applications, BMC Biotechnology, 13, 55, 10.1186/1472-6750-13-55 · DOI · Paper page
  11. 10.1016/j.molimm.2006.09.029 · DOI
  12. 10.1080/19420862.2015.1076600 · DOI
  13. 2018, Humanization of Antibodies using a Statistical Inference Approach, Scientific Reports, 8, 1
  14. 2018, Observed Antibody Space: A Resource for Data Mining Next-Generation Sequencing of Antibody Repertoires, The Journal of Immunology, 201, 2502, 10.4049/jimmunol.1800708 · DOI · Paper page
  15. 10.1080/19420862.2019.1633884 · doi:10.1080/19420862.2019.1633884 · Paper page
  16. 2019, Affinity Maturation Enhances Antibody Specificity but Compromises Conformational Stability, Cell Reports, 28, 3300, 10.1016/j.celrep.2019.08.056 · DOI · Paper page
  17. 2020, Human-likeness of antibody biologics determined by back-translation and comparison with large antibody variable gene repertoires, MAbs, 12, 1758291, 10.1080/19420862.2020.1758291 · DOI
  18. Marks, C. , Hummer, A. M. , Chin, M. , & Deane, C. M. (2021). Humanization of antibodies using a machine learning approach on large-scale repertoire data. Bioinformatics. https://doi.org/10.1093/bioinformatics/btab434 · DOI · Paper page
  19. Vaswani, A. , Shazeer, N. , Parmar, N. , Uszkoreit, J. , Jones, L. , Gomez, A. N. , … Polosukhin, I. (2017). Attention is all you need. Advances in Neural Information Processing Systems, 2017-Decem, 5999–6009. Neural information processing systems foundation.
  20. 2019, BERT: Pretraining of Deep Bidirectional Transformers for Language Understanding, Proceedings of the 2019 Conference of the North American Chapter of the Association for Computational Linguistics: Human Language Technologies, 1, 4171
  21. 2019, Exploring the Limits of Transfer Learning with a Unified Text-to-Text Transformer, Journal of Machine Learning Research, 21, 1
  22. Alley, E. C. , Khimulya, G. , Biswas, S. , AlQuraishi, M. , & Church, G. M. (2019). Unified rational protein engineering with sequence-based deep representation learning. Nature Methods. https://doi.org/10.1038/s41592-019-0598-1 · DOI · Paper page
  23. 10.1073/pnas.2016239118 · DOI · Paper page
  24. Rao, R. , Liu, J. , Verkuil, R. , Meier, J. , Canny, J. F. , Abbeel, P. , … Rives, A. (2021). MSA Transformer. BioRxiv, 2021.02.12.430858. https://doi.org/10.1101/2021.02.12.430858 · DOI · Paper page
  25. 10.1093/protein/gzz031 · DOI
  26. Mason, D. M. , Friedensohn, S. , Weber, C. R. , Jordi, C. , Wagner, B. , Meng, S. M. , … Reddy, S. T. (2021). Optimization of therapeutic antibodies by predicting antigen specificity from antibody sequence via deep learning. Nature Biomedical Engineering, 1–13. https://doi.org/10.1038/s41551-021-00699-9 · DOI · Paper page
  27. Amimeur, T. , Shaver, J. , Ketchem, R. , Taylor, J. A. , Clark, R. , Smith, J. , … Pettit, D. (2020). Designing Feature-Controlled Humanoid Antibody Discovery Libraries Using Generative Adversarial Networks. BioRxiv, 2020.04.12.024844. https://doi.org/10.1101/2020.04.12.024844 · DOI · Paper page
  28. Akbar, R. , Robert, P. A. , Weber, C. R. , Widrich, M. , Frank, R. , Pavlovic, M. , … Greiff, V. (2021). In silico proof of principle of machine learning-based antibody design at unconstrained scale. BioRxiv, 2021.07.08.451480. https://doi.org/10.1101/2021.07.08.451480 · DOI
  29. 2020, Predicting Antibody Developability Profiles Through Early Stage Discovery Screening, MAbs, 12, 1743053, 10.1080/19420862.2020.1743053 · DOI · Paper page
  30. 10.1080/19420862.2018.1548233 · DOI · Paper page
  31. 10.1093/nar/gki010 · DOI · Paper page
  32. McInnes, L. , Healy, J. , & Melville, J. (2018). UMAP: Uniform Manifold Approximation and Projection for Dimension Reduction. Retrieved from http://arxiv.org/abs/1802.03426 · arXiv
  33. 2019, Commonality despite exceptional diversity in the baseline human antibody repertoire, Nature, 566, 393, 10.1038/s41586-019-0879-y · DOI · Paper page
  34. 10.1006/jmbi.2001.4662 · DOI · Paper page
  35. 2003, IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains, Developmental and Comparative Immunology, 7, 55
  36. 10.1006/jmbi.1997.1354 · DOI · Paper page
  37. 10.1016/j.jmb.2010.10.030 · DOI · Paper page
  38. 2019, Thera-SAbDab: the Therapeutic Structural Antibody Database, Nucleic Acids Research, 48, 383
  39. 10.1093/bioinformatics/btv552 · DOI · Paper page
  40. 10.1007/s00251-015-0873-y · DOI · Paper page
  41. Ott, M. , Edunov, S. , Baevski, A. , Fan, A. , Gross, S. , Ng, N. , … Auli, M. (2019, July 21). fairseq: A Fast, Extensible Toolkit for Sequence Modeling. 48–53. https://doi.org/10.18653/v1/n19-4009 · DOI · Paper page
  42. Liu, Y. , Ott, M. , Goyal, N. , Du, J. , Joshi, M. , Chen, D. , … Stoyanov, V. (2019). RoBERTa: A Robustly Optimized BERT Pretraining Approach. Retrieved from https://arxiv.org/abs/1907.11692v1 · arXiv
  43. Vig, J. , Madani, A. , Varshney, L. R. , Xiong, C. , Socher, R. , & Rajani, N. F. (2020). BERTology Meets Biology: Interpreting Attention in Protein Language Models. Retrieved from http://arxiv.org/abs/2006.15222 · DOI · Paper page
  44. 2018, NGLview-interactive molecular graphics for Jupyter notebooks, Bioinformatics, 34, 1241, 10.1093/bioinformatics/btx789 · DOI · Paper page

Metadata

Authors
Prihoda, D., Maamary, J., Waight, A., Juan, V., Fayadat-Dilman, L., Svozil, D., & Bitton, D. A.
Affiliations
  • Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
  • Czech Academy of Sciences, Institute of Molecular Genetics (CZ)
  • MSD (Czech Republic) (CZ)
Corresponding author
Bitton, Danny A.
Venue
mAbs
Publisher
openRxiv
Published
2021-08-08
Volume
14
Issue
1
Pages
2020203-2020203
ISSN
1942-0862 (ISSN-L)
OpenAlex
W4220757565
Cited by
189
References
1
Citations by year
2026: 35 · 2025: 65 · 2024: 50 · 2023: 28 · 2022: 11
FWCI
21.88
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • mAbs (publishedVersion, cc-by-nc)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nd)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Ministerstvo Školství, Mládeže a Tělovýchovy (RVO-68378050-KAV-NPUI, RVO: 68378050, 68378050‐KAV‐NPUI, 68378050, LM2018130)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
Keywords
antibody humanization, therapeutic antibody design, immunogenicity prediction, language modeling, antibody discovery
MeSH terms
Deep Learning, Animals, Antibodies, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: BioPhi: A platform for antibody design, humanization and humanness evaluation based on natural antibody repertoires and deep learning. https://app.cochat.ai/papers/10.1101/2021.08.08.455394
The paper
Prihoda, D., Maamary, J., Waight, A., Juan, V., Fayadat-Dilman, L., Svozil, D., & Bitton, D. A. (2021). BioPhi: A platform for antibody design, humanization and humanness evaluation based on natural antibody repertoires and deep learning. mAbs. https://doi.org/10.1101/2021.08.08.455394

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.